Search

everythinglearnresearchcommunity

for

Search:↓

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

BPH is common in older men and often occurs with other age-related health issues.

Finasteride helps reduce heart issues and improves heart function.

Finasteride treatment can decrease certain steroids and increase others, possibly leading to depression symptoms in some cases.

St. John's Wort may reduce the effectiveness of finasteride by increasing its breakdown in the body.

Finasteride improves heart function and repairs damage after heart attack in mice.

Finasteride and dutasteride might lower melanoma risk.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

Different forms of finasteride dissolve and remain stable differently, affecting capsule quality.

Combining tamsulosin and finasteride effectively improves urinary symptoms in elderly BPH patients.

Alpha1-blockers effectively improve urinary symptoms in BPH, with alfuzosin and tamsulosin having fewer side effects.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Baldness score can't be used to predict prostate size.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.